e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Diagnosis and management of pleural and mediastinal diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Characteristics of malignant pleural effusions. Review of one-year data from a large tertiary centre
S. Bikmalla, M. Khalil, M. Ganaie, M. Haris (Stoke-on-Trent, United Kingdom)
Source:
Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Session:
Diagnosis and management of pleural and mediastinal diseases
Session type:
Thematic Poster Session
Number:
2931
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Bikmalla, M. Khalil, M. Ganaie, M. Haris (Stoke-on-Trent, United Kingdom). Characteristics of malignant pleural effusions. Review of one-year data from a large tertiary centre. Eur Respir J 2013; 42: Suppl. 57, 2931
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Challenges in the management of SCLC
Related content which might interest you:
Talc pleurodesis for malignant pleural effusion - effect on survival: Case-control follow-up study
Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma
Year: 2014
Malignant pleural effusion as the initial manifestation of gynecological malignancies
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016
Retrospective review of VATS (Pleural) negative biopsy and their outcome in a university hospital
Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside
Year: 2016
A feasibility study of pulmonary rehabilitation at home in patients with lung cancer or malignant pleural mesothelioma treated by (radio-)chemotherapy
Source: International Congress 2014 – Best abstracts in pulmonary rehabilitation and exercise training
Year: 2014
Survival of non small cell lung carcinoma patients with malignant pleural effusions
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Solitary fibrous tumour of the pleural: Two malignant cases
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015
Primary pulmonary sarcomatoid carcinoma: A case series
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Ideal volume sampling in the diagnosis of malignant pleural effusions. Just how much is really enough?
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013
A novel pleural-bladder pump for management of pleural effusion
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013
Blood-staining of pleural fluid is an inaccurate predictor of pleural malignancy
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015
An examination of the factors for successful pleurodesis against malignant pleural effusion (MPE)
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016
Survival analysis of pleural malignant mesothelioma (MM) at a single Institution in Liguria, Italy
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015
Predictive parameters of survival in malignant pleural effusion
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015
Malignant pleural effusion (MPE) as debut of cancer
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015
Differences according to age and sex among patients with malignant pleural effusion as a presentation form of cancer
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016
Risk of occult pleural infection in patients with malignant effusions
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013
Comparison analysis of malignant and tuberculous pleural fluid using proteomic method
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016
Outcome of patients with non specific pleuritis after medical thoracoscopy
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016
Lent score validation on patients with malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016
Malignant mesothelioma vs metastatic carcinoma of pleura: Do pathology and radiology agree?
Source: Annual Congress 2013 –Morphologic imaging
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept